Inhibition of the urea cycle by the environmental contaminant 2,3,7,8-tetrachlorodibenzo-p-dioxin increases serum ammonia levels in mice
Journal of Biological Chemistry · 2024
DOI: 10.1016/j.jbc.2023.105500 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biological Chemistry, 2024. Verfasst von Giovan N Cholico und 4 weiteren Autor:innen. Beteiligte Einrichtung: Biochemistry and Molecular Biology, Michigan State University, East Lansing, Michigan, USA; Institute for Integrative Toxicology, Michigan State Univ…. Hauptthemen laut MEDLINE: Ammonia, Non-alcoholic Fatty Liver Disease, Polychlorinated Dibenzodioxins, Metabolic Networks and Pathways. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 87 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIEHS NIH HHS, National Institute of Environmental Health Sciences, AgBioResearch, Michigan State University.
Abstract (Originalsprache)
The aryl hydrocarbon receptor is a ligand-activated transcription factor known for mediating the effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and related compounds. TCDD induces nonalcoholic fatty liver disease (NAFLD)-like pathologies including simple steatosis that can progress to steatohepatitis with fibrosis and bile duct proliferation in male mice. Dose-dependent progression of steatosis to steatohepatitis with fibrosis by TCDD has been associated with metabolic reprogramming, including the disruption of amino acid metabolism. Here, we used targeted metabolomic analysis to reveal dose-dependent changes in the level of ten serum and eleven hepatic amino acids in mice upon treatment with TCDD. Bulk RNA-seq and protein analysis showed TCDD repressed CPS1, OTS, ASS1, ASL, and GLUL, all of which are associated with the urea cycle and glutamine biosynthesis. Urea and glutamine are end products of the detoxification and excretion of ammonia, a toxic byproduct of amino acid catabolism. Furthermore, we found that the catalytic activity of OTC, a rate-limiting step in the urea cycle was also dose dependently repressed. These results are consistent with an increase in circulating ammonia. Collectively, the repression of the urea and glutamate-glutamine cycles increased circulating ammonia levels and the toxicity of TCDD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Biochemistry and Molecular Biology, Michigan State University, East Lansing, Michigan, USA; Institute for Integrative Toxicology, Michigan State University, East Lansing, Michigan, USA.
- Institute for Integrative Toxicology, Michigan State University, East Lansing, Michigan, USA; Microbiology & Molecular Genetics, Michigan State University, East Lansing, Michigan, USA.
- Biochemistry and Molecular Biology, Michigan State University, East Lansing, Michigan, USA; Institute for Integrative Toxicology, Michigan State University, East Lansing, Michigan, USA. Electronic address: tzachare@msu.…
Förderung
- NIEHS NIH HHS
- National Institute of Environmental Health Sciences
- AgBioResearch, Michigan State University
- National Institutes of Health
Zitieren
APA
Cholico, G. N., Fling, R. R., Sink, W. J., Nault, R., & Zacharewski, T. (2024). Inhibition of the urea cycle by the environmental contaminant 2,3,7,8-tetrachlorodibenzo-p-dioxin increases serum ammonia levels in mice. Journal of Biological Chemistry. https://doi.org/10.1016/j.jbc.2023.105500
Vancouver
Cholico GN, Fling RR, Sink WJ, Nault R, Zacharewski T. Inhibition of the urea cycle by the environmental contaminant 2,3,7,8-tetrachlorodibenzo-p-dioxin increases serum ammonia levels in mice. Journal of Biological Chemistry. 2024. doi:10.1016/j.jbc.2023.105500
BibTeX
@article{Cholico2024,
author = {Cholico, Giovan N and Fling, Russell R and Sink, Warren J and Nault, Rance and Zacharewski, Tim},
title = {Inhibition of the urea cycle by the environmental contaminant 2,3,7,8-tetrachlorodibenzo-p-dioxin increases serum ammonia levels in mice},
journal = {Journal of Biological Chemistry},
year = {2024},
doi = {10.1016/j.jbc.2023.105500}
}
EUVIMED